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Triptolide (TP), one of the major active components of the traditional Chinese herb
Tripterygium wilfordii Hook F, and 2, 4-diamino-6-hydroxypyrimidine (DAHP), an inhibitor
of tetrahydrobiopterin (BH4) synthesis, have been reported to have potent anti-
inflammatory and immunosuppressive properties. However, the protective effects of
TP and DAHP on cerebral ischemia have not been reported yet. In this study, we
investigated the neuroprotective effects of TP and DAHP in a middle cerebral artery
occlusion (MCAO) rat model. Furthermore, we examined whether the neuroprotective
effects of TP and DAHP were associated with the inhibition of apoptosis through
suppressing BH4 and inducible NOS (iNOS) synthesis or the activation of the
phosphoinositide-3-kinase/serine-threonine kinase Akt/mammalian target of rapamycin
(PI3K/Akt/mTOR) pathway. Our results showed that pretreatments with TP (0.2 mg/kg)
and DAHP (0.5 g/kg) significantly reduced ischemic lesion volume, water content, and
neuronal cell death compared with the vehicle MCAO rats. In addition, compared
with the MCAO group, TP, and DAHP pretreatment groups significantly reduced
astrocyte numbers, caspase-3, cleaved caspase-3, and NF-κB up-regulation, while
increased Bcl-2 expression. Moreover, protein expressions of PI3K, Akt, and mTOR
increased, while extracellular signal-regulated protein kinases 1 and 2 (ERK1 and ERK2)
phosphorylation decreased in both the TP-treated rats and DAHP-treated rats. These
results demonstrate that TP and DAHP can decrease cell apoptosis in focal cerebral
ischemia rat brains and that the mechanism may be related to the activation of the
PI3K/Akt/mTOR pathway and inactivation of the ERK1/2 pathway. Thus our hypothesis
was reached PI3K/Akt/mTOR and ERK1/2 pathways may provide distinct cellular
targets for a new generation of therapeutic agents for the treatment of stroke, and TP
and DAHP may be potential neuroprotective agents for cerebral ischemia/reperfusion
injury.
Keywords: cerebral ischemia, DAHP, Triptolide, PI3K/Akt/mTOR, anti-apoptosis, neuroprotection
Abbreviations: DAHP, 2, 4-diamino-6-hydroxy-pyrimidine; DMSO, dimethyl sulfoxide; ERK, extracellular signal-regulated
kinase;MCAO,middle cerebral artery occlusion; MRI,magnetic resonance imaging; mTOR,mammalian target of rapamycin;
PI3K, Class III phosphatidylinositol kinase; PVDF, polyvinylidine diﬂuoride; TTC, 2, 3, 7-triphenyltetrazolium chloride;
TUNEL, terminal dexynucleotidyl transferase (TdT)-mediated dUTP nick end labeling.
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Introduction
Stroke is a disease of serious consequence to human health with
high prevalence worldwide. The increasing number of patients
who suﬀer from stroke is estimated to reach more than 200 mil-
lion a year with almost 150 million deaths annually (Tang et al.,
2012). Cerebral ischemia accounts for 87% of all stroke patients
and is one of the major causes of death and the third cause of dis-
ability (Suethanapornkul et al., 2008; Urban et al., 2010; Writing
Group et al., 2010). Thus, it is essential to study the mechanisms
underlying cerebral ischemia, and ﬁnding eﬀective therapeutic
strategies has become an urgent task to prevent neural damage
in ischemic brain injury.
Apoptosis after cerebral ischemia is one of the major path-
ways that lead to the process of cell death (Mattson et al., 2001).
In response to oxidative stress in mitochondria, the outer mem-
brane of mitochondria becomes permeable. This phenomenon
is directly controlled by Bcl-2 family, resulting in the translo-
cation of Bax from the cytosol to the mitochondria and the
release of cytochrome c (Kuwana et al., 2002). Cytochrome c is
then released from the mitochondrial inter-membrane space to
the inner cytosol, leading to the formation of the apoptosome
together with Apaf-1 and caspase-9. The apoptosome permits the
auto-activation of procaspase-9, which is followed by the activa-
tion of procaspase-3. Active caspase-3 which is cleaved caspase-3
leads to cell apoptosis by proteolysis such as DNA fragmentation.
Previous studies have demonstrated that DNA fragmentation
contributes to the development of ischemic infarction (Yao et al.,
2012). Thus, the ideal preventive or therapeutic approach would
indeed target apoptosis after cerebral ischemia.
Previous studies have shown that activation of the phosphoi-
nositide-3-kinase/serine-threonine kinase Akt/mammalian
target of rapamycin (PI3K/Akt/mTOR) pathway may play an
important role in the eﬀects of cell proliferation and apoptosis in
the brain (Annovazzi et al., 2009). The neuroprotective role of the
PI3K/Akt pathway in cerebral ischemia has been widely studied
(Shibata et al., 2002; Xu et al., 2008). Activation of the PI3K/Akt
pathway has been proved to negatively modulate genes that pro-
mote inﬂammation, thrombogenicity, and vascular permeability,
and thereby protect vascular function (Schabbauer et al., 2004).
Activated Akt can rapidly modulate some molecular functions
including mTOR. As a multifunctional collection point, mTOR
regulates cytotrophy, energy supply, and signal transduction, and
also promotes protein synthesis, angiogenesis and the process
of the cell cycle. Given the neuroprotective role of the PI3K/Akt
pathway, we hypothesized that the PI3K/Akt/mTOR pathway
may be inactivated after cerebral ischemia injury. In this study
we prove that this is indeed the case in the MCAO model
rats.
It is widely known that protein kinase-mediated signaling cas-
cades play a vital role in perceiving extracellular signals and
evoking downstream cellular response in neural cells (Irving
et al., 2000). The ERK pathway is one of such important sig-
nal systems (Li et al., 2003; Huang et al., 2010). Extracellular
signal-regulated protein kinases 1 and 2 (ERK1/2), which are
members of the mitogen-activated protein kinase family, have
been well characterized and are known to be involved in cell
survival. However, some evidences have suggested that the acti-
vation of ERK1/2 also contributes to cell death in some cell
types and organs under certain conditions (Dong et al., 2004;
Kim et al., 2005; Zhuang and Schnellmann, 2006). Several studies
have proved that cooperative activation of ERK and Akt promote
cell survival through, respectively, suppressing distinct apoptotic
mechanisms, whereas other evidences have suggested that ERK
also contribute to cell death through suppressing Akt, one of
the anti-apoptotic signaling molecules (Xue et al., 2000; Sodhi
et al., 2001; Sinha et al., 2004). Therefore, the functional relation-
ship between ERK and Akt after ischemic insults and whether
mTOR is the downstream target of Akt that regulates neuron
survival in ischemic brain injury require further investigation.
In this present study, we investigated spatiotemporal expressions
of ERK1/2 and PI3K/Akt/mTOR signals in the rat brain after
MCAO.
Tetrahydrobiopterin (BH4) is an essential cofactor for NOS
activity which is derived from peroxynitrite (ONOO) during
ischemia/reperfusion and contributes to ischemic brain injury.
DAHP an inhibitor of BH4 synthesis, signiﬁcantly decreased gas-
tric nitric oxid (NO) release and nitrergic relaxation. Reduced
infarct volume in a MCAO rat model treated with DAHP
has been reported (Kidd et al., 2005; Gangula et al., 2010).
Although previous studies established a deleterious role of iNOS
in ischemic stroke, the regulatory mechanisms for iNOS and the
biological mechanism of DAHP in MCAO remain unknown.
As a component of traditional Chinese medicine, Triptolide
(TP) has been widely used in a variety of inﬂammatory and
autoimmune disease treatments such as rheumatoid arthritis
treatment for its functions in antitumor, anti-inﬂammatory,
and immune suppression. Furthermore, the neuroprotective
eﬀect of TP on dopaminergic neurons in MPP+-induced hemi-
parkinsonian rats has also been reported (Gao et al., 2008).
Also, TP restrains NF-κB signal transduction pathway in astro-
cyte through inhibiting the activation of microglia (Jiang
et al., 2001; Zhao et al., 2005). However, the speciﬁc antag-
onist eﬀects of TP on cerebral ischemia injury need further
exploration.
The aim of this study was to investigate whether brief
administrations of DAHP (0.2 mg/kg) and TP (0.5 g/kg) 12 h
before MCAO salvage neurons from inevitable injury dur-
ing reperfusion (90 min). We further tested the hypothesis
that these beneﬁcial actions are mediated activation of the
PI3K/Akt/mTOR signaling pathway through inhibiting apoptotic
mechanism.
Materials and Methods
Animals
Adult male Sprague–Dawley rats (the Animal Center of Zhejiang
University, China), weighing 230–250 g, were used in the exper-
iments. Animals were maintained under special pathogen-free
conditions and have free access to sterilized water and pellet
food. These rats were kept under standardized conditions with
a 12 h light–dark cycle. Temperature (24 ± 1◦C) and humid-
ity (55%) remained constant. All experiments were conducted in
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compliance with the National Institute of Health’s Guidelines for
the Care and Use of Laboratory Animals.
Middle Cerebral Artery Occlusion
According to previous research, male Sprague–Dawley rats were
subjected to perform MCAO and reperfusion operations (Longa
et al., 1989). Brieﬂy, rats were anesthetized with 4% chloral
hydrate intraperitoneally. Then MCAO was carried out using
an intraluminal thread introduced via common carotid artery
(CCA). A surgical midline incision was made to expose the
right CCA, external carotid artery (ECA), and internal carotid
artery (ICA). A 4-0-monoﬁlament nylon suture with approxi-
mately 0.26 mm round in diameter was inserted into the right
CCA lumen and gently advanced into the ICA up to a point
approximately 18 mm. After 90 min, the nylon sutures were
slowly removed from the artery, and the animals were allowed
reperfusion. Then we closed the incision on the neck. Using
an automatic homeothermic blanket control unit, the animal’s
body temperature was continually monitored and maintained at
37◦C throughout the surgical procedure and during post-surgery
recovery.
Drug Administration and Experimental
Groups
A total of 60 adult male Sprague–Dawley rats were randomly
seperated into 5 groups: (1) control group (n = 12), (2) DMSO
group (n = 12), (3) MCAO group (n = 12), (4) DAHP-treated
group (n = 12), and (5) TP-treated group (n = 12). The control
group (sham operated animals) underwent the MCAO surgical
procedure, except the thread was not inserted into the CCA.
The animals in the DMSO group were almost same with the
control group except giving intraperitoneal injection of 0.5 ml
DMSO. In TP-treated and DAHP-treated groups, animals went
through the MCAO surgical procedure, and TP and DAHP
were administrated by intraperitoneal injection (i.p.) 12 h before
the beginning of MCAO at a dose of 0.2 mg/kg and 0.5 g/kg,
respectively, (Kidd et al., 2005; Klawitter et al., 2012; Lee et al.,
2012; Yang et al., 2015). TP and DAHP were obtained from
Merck and dissolved in DMSO. All the tissue samples were
collected at the same time point, 24 h after MCAO surgical
procedure.
Evaluation of Cerebral Edema and Infarction
TTC
The rats were injected intraperitoneally with sodium pentobarbi-
tal (40 mg/kg). After being anesthetized, the brains were removed
rapidly and frozen in −20◦C for 30 min. Brains were dissected,
and coronal slices (2 mm in thickness) were acquired from frozen
forebrains using a rodent brain matrix slicer. Brain slices were
then stained with TTC (2%) at 37◦C for 20 min in dark. The
sections were soaked in 4% paraformaldehyde phosphate buﬀer
for 1 h and scanned. The percent of infarct area of the entire
brain represented the degree of cerebral infarction. Normal brain
tissues were stained red, while the unstained (white)area was con-
sidered to be the infract area. Areas of red and white staining
were measured using a computer color multimedia image anal-
ysis system (Image J 1.46R, NIH, USA). The percent of infarction
is revealed by the equation: % infarct area= infarct area/total area
of slice × 100 (Cheng et al., 2012).
MRI Examination
The rats in each group were examined by MRI to investigate
whether the rats displayed signs of hemispheric swelling and
oedema formation. Rat brains were then tested in a 3.0-Tesla
(T) MRI animal scanner (Magnetom Trio with TIM system,
Siemens, Erlangen, Germany). In order to obtain the signal
excitation and detection, the rat’s head was placed in a custom-
made “birdcage coil,” which has a 30 mm inner diameter. MRI
parameters were set as follows: TE = 92 ms, TR = 3620 ms,
FOV = 8 cm × 8 cm, M = 256 × 256, NA = 2, thick-
ness = 2 mm, and gap = 0 mm. The rat was held in a ﬂat skull
position, and the brain was performed to center the image slice
5 mm posterior to the rhinal ﬁssure. Image-Pro Plus 5.0 software
(Media Cybernetic, Bethesda,MD, USA) was used to examine the
hemisphere intensity by “mean density value” after the optimal
adjustment of contrast. MRI measurements were obtained 24 h
after MCAO.
Immunofluorescence
Brains were perfusion ﬁxed with 4% paraformaldehyde and 30%
sucrose solution before processing for histology. After being
frozen, brains were sectioned coronally. Primary antibodies were
applied in the following concentrations: GFAP and iNOS (1:100;
Santa Cruz Biotechnology, Inc., USA). Immunohistochemistry
followed the method with HRP-conjugated goat anti-rabbit IgG
(1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
then were visualized with 3, 30-diaminobenzidine (DAB, Sigma,
St. Louis, MO, USA). Sections were then hydrated, cleared and
mounted in DXP for microscopic analysis. Immunoﬂuorescence
followed with appropriate secondary antibodies (Alexa Fluor,
Molecular Probes Inc.) in 1% BSA and 0.3% Triton X-100 in PBS
after primary antibodies. Mounting medium was added on the
slides prior to be covered with coverslips for observation by a
laser scanning confocal microscope.
Western Blot
Total proteins of the ischemic penumbra brain tissue were
extracted from tissues of each group with 2 mM phenylmethane-
sulfonyl ﬂuoride in 1 mL ice-cold RIPA buﬀer added protease
inhibitor cocktail EDTA-free and phosphates inhibitors. BCA kit
(KeyGEN, Nanjing, China) was used to determine protein con-
centration. A total of 30 μg of total protein from each sample was
subjected to electrophoresis on 12% SDSPAGE gel using a con-
stant voltage. After performing electrophoresis 70 V for 30 min
and 100 V for 120 min, the proteins were electrophoretically
transferred to PVDFmembrane using a Bio-Rad TransBlot appa-
ratus for 120 min. The PVDF membranes were blocked with
TBST containing 5% non-fat milk for 2 h at room temperature,
and then incubated with rabbit anti-ERK1/2 and Bcl-2 (1:1000;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), caspase-3,
cleaved caspase-3, NF-κB, pERK1/2, Phospho-Akt (Ser473), and
Akt (1:1000; Cell Signaling Technology, Inc., USA), mTOR and
PI3K (1:1000; Epitomics, USA) primary antibody overnight at
4◦C. The membrane was washed with TBS containing 0.05%
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FIGURE 1 | T2-weighted MRI images of rats’ brain.
FIGURE 2 | 2, 4-diamino-6-hydroxypyrimidine and Triptolide (TP)
reduced focal cerebral ischemia-induced injury. (A) Representative
photographs of coronal brain sections stained with 2,3,5-triphenyltetrazolium
chloride. (B) Summary of cerebral infarct size in brains. The infarct volume
was expressed as the percentage of the contra lateral hemispheric area.
Infarction size was then analyzed using Meta-Morph program. Data were
expressed as mean ± SD, ∗∗P < 0.01 vs. control group; ##P < 0.01 vs.
MCAO group.
Tween 20 (TBST) for 15 min and three times, then incubated
with horseradish peroxidase-conjugated goat anti-rabbit (1:3000;
Jackson Immuno Research Laboratories, USA) antibody for 2 h,
and then washed with TBST for 15 min and three times. Finally,
membranes were processed for detection using the ECL system.
The band density was analyzed by Quantity One, and all exper-
iments performed in triplicate to represent the mean plus or
minus SD of all data.
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FIGURE 3 | Detection of neuronal apoptosis. (A) TUNEL staining was used to identify apoptotic cells. (B) TUNEL positive cells were counted using Meta-Morph
program. TUNEL positive cells show the quantitative analysis data. Data are expressed as mean ± SD, ∗∗P < 0.01 vs. control group; ##P < 0.01 vs. MCAO group.
TUNEL Staining
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin
nick end labeling staining was assessed by the In Situ Cell
Death Detection Kit, POD (Roche Applied Science, Mannheim,
Germany). After 24 h reperfusion, the sections were prepared
and the staining was performed according to the protocol pro-
vided by the manufacturer. Confocal laser scanning micro-
scope was employed to analyze the results. The number of
TUNEL positive neurons and total neurons was counted in
three diﬀerent ﬁelds for each section and calculated in 10
selected sections by an examiner blinded to the group assign-
ment. The extent of apoptosis was calculated and expressed
as a ratio of TUNEL-positive neurons versus total neurons
(Wang et al., 2012).
Statistical Analysis
The data were analyzed using Graph Pad Prism version 4.0.
Values are presented as means ± SD for the indicated anal-
yses. A probability value of P < 0.05 was considered to be
statistically signiﬁcant for all statistical tests. To compare mean
values in two separate groups for infarct volume, we used
an unpaired t-test. Values of P < 0.05 were considered sig-
niﬁcant. Western-blot had been evaluated by Quantity one
analysis. Diﬀerences at P < 0.05 were considered statistically
signiﬁcant.
Results
DAHP and Triptolide Improve Edema
Magnetic resonance imaging is considered to be the most promis-
ing and non-invasive approach for examining brain edema.
Assessment of hemispheric volumes on MRI allows a direct
quantiﬁcation of the space-occupying eﬀect in experimental
stroke. T2-weighted MRI is frequently used to determine the
edema induced by I/R. The representative images were shown in
Figure 1. Brain edema was hardly observed in the animals of the
control group. In contrast, edemawas detected at 24 h after reper-
fusion in MCAO group. The brain edema was less in both the
DAHP-treated and TP-treated groups.
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Triptolide and DAHP Reduce Infarction
Volume and Brain Water Content
2, 3, 7-triphenyltetrazolium chloride staining reﬂected the neu-
rological deﬁcit in the rat brain. The representative images are
presented in Figure 2A. There were signiﬁcant diﬀerences in
lesion areas between rats in the control group andMCAO groups
(P < 0.01). The lesion area in the TP and DAHP pre-treatment
groups were reduced noticeably compared with the model group
(P < 0.01). The area of the lesion in the DMSO group showed no
signiﬁcant diﬀerence from the model group. In the TP andDAHP
treated groups, the area of the lesion was reduced, but no signiﬁ-
cant diﬀerence was found when compared with the DMSO group
in Figure 2B.
Triptolide and DAHP Reduces Apoptotic Cell
Death in the Brain
At the 24 h time point after reperfusion, the number of apop-
totic cells in penumbral area was observed. Apoptotic cells
were recognized by TUNEL which is the identiﬁcation of DNA
fragmentation. As can be seen from Figure 3, in the MCAO
and DMSO group, the numbers of TUNEL positive cells were
signiﬁcantly increased, as compared to sham rats. In the TP-
treated and DAHP treated group, the numbers of TUNEL posi-
tive cells were signiﬁcantly decreased, as compared to the MCAO
group. These results suggested that the TP-treated and DAHP-
treatment eﬀectively prevented expansion of apoptotic cell death
in MCAOmodel. Data is expressed as mean± SD, ∗∗P< 0.01 vs.
control group; ##P < 0.01 vs. MCAO group.
Triptolide and DAHP Reduce Glial Activation
To speciﬁcally investigate the eﬀect of MCAO on astrocyte func-
tion and TP and DAHP on the neuroinﬂammatory system,
we measured the expression of GFAP following ischemic insult
by immunoﬂuorescence staining analysis at 24 h after reper-
fusion. The number of GFAP-positive astrocytes was observed.
In the MCAO group, the GFAP-positive astrocytes were mainly
gathered in the penumbral area. In TP-treated and DAHP-
treated rats, the number of GFAP-positive astrocyte accumulation
FIGURE 4 | 2, 4-diamino-6-hydroxypyrimidine and TP treatments
attenuated ‘reactive gliosis’ in the ischemic area. (A) Immuno-
fluorescence staining showed immunoreactivities of GFAP after MCAO.
The profound expression of GFAP was observed in MCAO group
compared to control group (B). The expression of GFAP in DAHP-
treated and TP-treated group was significantly decreased compared with
MCAO group. ∗∗P < 0.01 vs. MCAO group; #P < 0.05 vs. MCAO
group.
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signiﬁcantly decreased compared to the MCAO rats (Figure 4).
The result showed that the inhibitory eﬀects of TP and DAHP
on GFAP-positive astrocyte might contribute to its neuroprotec-
tive eﬀect in MCAO. ∗∗P < 0.01 vs. MCAO group; #P < 0.05 vs.
MCAO group.
Triptolide and DAHP Attenuate the
Increasing of iNOS
As shown in Figure 5A, immunochemistry results revealed
that stroke increased the iNOS activity when compared with
non-ischemic rats. Ischemic reperfusion induced a substan-
tial increase in iNOS activity, which was signiﬁcantly atten-
uated by TP and DAHP. In comparison with DAHP, the
extent of reduction of increased iNOS activity induced by
ischemic reperfusion was higher by TP treatment (Figure 5B).
Immunoreactive stainings of iNOS was detected in the cerebral
cortex. The staining for iNOS was moderately expressed in the
ischemic penumbral cortex (Figure 5A). ∗∗P < 0.01 vs. con-
trol group; ##P < 0.01 vs. MCAO group; #P < 0.05 vs. MCAO
group.
Triptolide and DAHP Activated the PI3K/Akt/
mTOR Pathway and Increased the
Expression of Bcl-2
Western blot analysis revealed that stroke decreased the activ-
ity of PI3K/Akt/mTOR pathways compared with non-ischemic
rats. Treatments with TP and DAHP signiﬁcantly increased
PI3K, Akt and mTOR expression compared to the MCAO
group (Figures 6A,C–E). Compared with the sham-operated
rats, the protein expression of Bcl-2 signiﬁcantly decreased
in the MCAO rats (Figure 6B). Pretreatments of TP and
DAHP signiﬁcantly increased the protein expression of Bcl-
2 TP and DAHP vs. MCAO group. ∗∗P < 0.01 vs. MCAO
group; ##P < 0.01 vs. MCAO group; #P < 0.05 vs. MCAO
group.
Triptolide and DAHP Decreased the
Expression of Caspase-3, NF-κB, and
Cleaved Caspase-3
Figure 7A shows the results of western blot with caspase-3, NF-
κB and cleaved caspase-3 antibodies in cortex of rats 24 h after
MCAO. Increased protein level of NF-κB was observed 24 h
after MCAO. TP and DAHP decreased the protein expressions
of NF-κB. Also, the expressions of caspase-3 and cleaved caspase-
3 were analyzed by western blot. The data showed that TP and
DAHP signiﬁcantly decreased the protein expressions of caspase-
3 and cleaved caspase-3 (Figures 7A–D). ∗∗P < 0.01 vs. control
group; ∗P < 0.05 vs. control group; #P < 0.05 vs. MCAO group;
##P < 0.01 vs. MCAO group.
Triptolide and DAHP Decreased
pERK1/ERK1 and pERK2/ERK2 Expressions
ERK1, ERK2, phospho-ERK1 (pERK1), and phospho-ERK2
(pERK2) expressions were examined after MCAO using west-
ern blot and immunoﬂuorescence staining. The results showed
that ERK1, ERK2, pERK1, and pERK2 were detected after 90 min
of MCAO in both the ischemic core and the perifocal regions.
Western blot analysis showed that levels of pERK1/ERK1 and
FIGURE 5 | 2, 4-diamino-6-hydroxypyrimidine and TP treatments
attenuated iNOS expression in ischemic area. (A) Immunohisto-
chemistry showed immunoreactivities of iNOS after MCAO. The profound
expression of iNOS was observed in MCAO group compared to control
group (B). The expression of iNOS in DAHP-treated and TP-treated group
was significantly decreased compared with MCAO group. ∗∗P < 0.01 vs.
control group; ##P < 0.01 vs. MCAO group; #P < 0.05 vs. MCAO
group.
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FIGURE 6 | 2, 4-diamino-6-hydroxypyrimidine and TP treatments
rescued the decreased levels of PI3K, phosphorylated Akt
Ser-473, and mTOR induced by ischemia in the cortex and
hippocampus, also restored the decreased level of Bcl-2 induced
by ischemia. (A) Compared with the control group, the PI3K, Akt,
and mTOR protein levels decreased in the MCAO group. And it
restored the decreased level of Bcl-2 (B) induced by ischemia DAHP
and TP up-regulated the protein levels of PI3K (C), Akt (D), and
mTOR (E). ∗∗P < 0.01 vs. MCAO group; ##P < 0.01 vs. MCAO
group; #P < 0.05 vs. MCAO group.
pERK2/ERK2 were obviously increased after 90 min of MCAO
in comparison with sham-operated group. Treatments with TP
and DAHP decreased the expressions of pERK1/ERK1 and
pERK2/ERK2 (Figures 8A–C). ∗∗P < 0.01 vs. control group;
∗P < 0.05 vs. control group; #P < 0.05 vs. MCAO group;
##P < 0.01 vs. MCAO group.
Discussion
The research for neuroprotective agents in MCAO is primarily
based on the abilities of speciﬁc drugs to reduce neuronal loss
and contribute to cell survival. Agents that can provide such
neuroprotective eﬀects have the potential to become novel thera-
peutics for MCAO. Existing animal models of MCAO provide us
with useful tools to test the two new neuroprotective agents and
strategies. In this in vivo ischemia study the spatiotemporal pro-
ﬁle of PI3K/Akt/mTOR pathway was examined in a rat transient
MCAOmodel to investigate the mutual role of signal pathways.
Cerebral ischemia signiﬁcantly promoted the neurological
damage and increased total infarct size. The results showed that
rats undergoing ischemic stress exhibited a high percentage of
TUNEL-positive cells; however, these weremarkedly decreased in
the peri-infarct area in TP-treated and DAHP-treated rats. These
observations suggest that apoptosis is one of the major mech-
anisms that leads to cell death in the ischemic cortex. Several
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FIGURE 7 | 2, 4-diamino-6-hydroxypyrimidine and TP treatment
inhibited the expressions of caspase-3 (A), NF- κB and cleaved
caspase-3. The expression of caspase-3 (B), NF-κB (C) and cleaved
caspase-3 (D) was increased in MCAO group compared to control
group. DAHP and TP treatment significantly reduced the expression of
caspase-3, NF-κB and cleaved caspase-3. ∗∗P < 0.01 vs. control
group; ∗P < 0.05 vs. control group; #P < 0.05 vs. MCAO group;
##P < 0.01 vs. MCAO group.
studies have suggested that inhibiting glial activation attenuates
ischemic injury and neuronal death (Suk, 2004; Wang et al.,
2005). Like many other neurodegenerative disorders, the reactive
gliosis associated with ischemic stroke involves astrocytes (Kriz,
2006). Reactive gliosis can produce excess amounts of cytokines
as well as inﬂammatory products that exacerbate ischemic dam-
age (Walker and Rosenberg, 2009). In the present study, TP and
DAHP suppressed the increasing number of GFAP-positive cells
in the peripheral area and central ischemic core of the ischemic
infarct. There are papers reported that NO derived from iNOS
contributes to neuronal injury after cerebral ischemia reperfu-
sion, during which NO interacts with superoxide anion (O2) to
form ONOO and causes neuronal death (Oliver et al., 1990). An
increase in iNOS protein expression has been proved after cere-
bral ischemia in this paper, which is consistent with that in vivo
DAHP can reduce cerebral infarction via inhibiting iNOS activity
and ONOO level in transient focal ischemia, and iNOS inhibitor
can protect against neuronal injury in ischemic stroke (Kolinsky
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FIGURE 8 | 2, 4-diamino-6-hydroxypyrimidine and TP treatment
attenuated the increasing expressions of pERK1/ERK1 and
pERK2/ERK2. (A) The expressions of pERK1/ERK1 and pERK2/ERK2
were increased in MCAO group compared to control group. DAHP and
TP treatment significantly attenuated the increasing expressions of
pERK1/ERK1 (B) and pERK2/ERK2 (C). ∗∗P < 0.01 vs. control group;
∗P < 0.05 vs. control group; #P < 0.05 vs. MCAO group;
##P < 0.01 vs. MCAO group.
and Gross, 2004; Kidd et al., 2005). In contrast to DAHP, TP
plays a more positive role in decreasing iNOS activity. These
results indicate that the neuroprotective eﬀects of TP and DAHP
may be mediated by eﬀectively preventing against infarct expan-
sion through secondary injury caused by activated astrocytes and
iNOS-induced oxidative stress in focal cerebral ischemia.
Neural cell death resulting from cerebral ischemia involves
both the necrotic and apoptotic mechanisms. Extracellular sig-
nals often result in simultaneous activation of Akt pathway,
and many reports suggest a survival role of Akt signal pathway
through suppression of apoptosis (Xue et al., 2000; Li et al., 2003).
There have been evidenced that Akt indirectly activates NF-κB
transactivation by dissociation of phosphorylated Iκ-B kinase,
resulting in transcription of pro-survival genes like B-cell lym-
phomaextra large (Bcl-xL) and trophic factors (Jeon et al., 2012).
The expression of pro-survival factors such as Bcl-2 and Akt
decreased after ischemic injury but increased in TP-treated and
DAHP-treated groups. This shows that apoptosis plays a vital role
in stroke and also the anti-apoptosis eﬀects of TP and DAHP.
Activation of apoptotic pathways is always concomitant with
the survival signaling pathways. PERK1/ERK1, pERK2/ERK2,
pAkt/Akt, and mTOR expressions suggest that ERK1/2 and
PI3K/Akt/mTOR signal pathways play essentially an independent
role, especially after ischemic insults. The PI3K/Akt signaling
pathway plays a key role in many cellular processes, including cell
survival, coagulation, and inﬂammation responses. Furthermore,
activation of the PI3K/Akt pathway in cerebellar granule neurons
has been proposed to prevent neuronal cell death by suppressing
JNK activation (Shimoke et al., 1999). In the present study, we
demonstrated that pAkt andmTOR signiﬁcantly decreased in rats
after ischemic injury, but increase markedly in TP-treated and
DAHP-treated groups. MTOR promotes angiogenesis, neuronal
regeneration, and synaptic plasticity. It can further reduce neu-
ronal apoptosis, and remove neurotoxic substances, which are
all closely associated with the repair and survival mechanisms of
ischemic brain injury (Chen et al., 2012a). And there has been
demonstrated that mTOR inhibition by rapamycin increased
neuronal apoptosis in the early phase of neonatal HI brain injury,
leading to an increase in cleaved caspase-3 (Chen et al., 2012b).
These results thus indicate that PI3K/Akt/mTOR pathways may
play an important role in the extrinsic apoptosis pathway reg-
ulating neurotoxic substances and inﬂammation responses in
ischemic brain injury, consequently resulting in increased neu-
ronal survival. Recently, it was reported that ERK1/2 activation
that was accompanied by a gradual decrease in Akt activity and
apoptosis and inhibition of ERK1/2 prevented the decline in Akt
activity and resulted in cell survival (Sinha et al., 2004). These
results may suggest that ERK1/2 activation in response to sur-
vival factor deprivation contributed to cell death via suppressing
the PI3K/Akt/mTOR pathway. Several studies have revealed that
the intrinsic pathway is characterized by mitochondrial outer
membrane permeabilization, cytochrome c release, caspase-3
activation, DNA fragmentation, and death-inducible signaling
complex formation, and these events have been shown to be
associated with ERK activation (Wang et al., 2000; Jo et al.,
2005; Kim et al., 2005). In the present study, caspase-3, cleaved
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caspase-3, ERK1, and ERK2 expression increasedmarkedly under
chemic stress, while decreased in groups treated with TP and
DAHP. Pre-treatments of animals with TP and DAHP prior to
ischemic injury contributed to the decreased ERK1/2 staining,
which may prevent primary neuronal damage. Further investi-
gations are required to clarify more details of these molecular
balances with other signaling systems that lead cells to survival or
death.
In summary, many signal transduction systems are reg-
ulated following the onset of focal cerebral ischemia, some
of which may be protective and some may stimulate subse-
quent cellular degeneration. Activation of the PI3K/Akt/mTOR
pathway plays an essential mechanism for maintaining cellu-
lar homeostasis when responding to focal cerebral ischemia.
Activation of the ERK1/2 pathway has been implicated in
the mechanisms underlying cerebral ischemia, i.e., decreased
lesion volumes have been demonstrated following the admin-
istration of speciﬁc inhibitors (Irving et al., 2000; Irving
and Bamford, 2002). However, data presented here clearly
indicates that the ERK1/2 pathway is activated in a dif-
ferent spatial location within the ischemic brain. Both
pre-treatments of TP and DAHP clearly demonstrated their
protective eﬀects in focal cerebral ischemia through activa-
tion of PI3K/Akt/mTOR pathway and inactivation of ERK1/2
pathway. DAHP may provide neuroprotection through inhibit-
ing iNOS-induced oxidative stress within neurons and glia,
thus directly protecting these cells. In contrast, TP may exert
protection of all cellular elements via the inhibition of the
brains inﬂammatory response to injury and immune sup-
pression. These ﬁndings provide a mechanistic basis for new
therapeutic strategies aiming to regulate PI3K/Akt/mTOR
and ERK1/2 pathways in order to prevent against injuries
induced by focal cerebral ischemia. And TP and DAHP may
be considered to be potential therapies for focal cerebral
ischemia.
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